Overview

Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical Practice

Status:
Unknown status
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
A Drug Utilisation Survey is performed to monitor and document the drug utilisation patterns of Samsca in routine medical practice. A Post-Authorisation Safety Study is performed to collect information on the safety of Samsca when used in a real-life setting.
Details
Lead Sponsor:
Otsuka Frankfurt Research Institute GmbH
Treatments:
Tolvaptan